According to our results, the MAPK signaling pathway as an effective subnetwork of TCR and BCR signaling in SLE pathogenesis [59] also displayed a significant dysregulation, especially higher expression of MAPK1, MAPK3, and PPP3CA genes. This evidence concerns the gene MAPK1 and systemic lupus erythematosus.